ロード中...
MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer
Targeted therapy for metastatic diseases relies on the identification of functionally important metastasis genes from a large number of random genetic alterations. Here we use a computational algorithm to map minimal recurrent genomic alterations associated with poor-prognosis breast cancer. 8q22 ge...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2676231/ https://ncbi.nlm.nih.gov/pubmed/19111877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2008.11.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|